Investigation of Digital Media Use in Patients Receiving Chemotherapy

NCT07501871 | Not Yet Recruiting

• 1 other identifier: ASG-YILDIZ-002
• Study Type: observational
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to examine digital media use and eHealth literacy among patients receiving chemotherapy. Digital media has become an important tool for accessing health information, communicating with healthcare providers, and supporting self-management. This observational study will be conducted with adult patients receiving chemotherapy in an outpatient setting. Data will be collected using a sociodemographic information form and the eHealth Literacy Scale (eHEALS). The findings are expected to contribute to a better understanding of digital media use and digital health literacy levels in chemotherapy patients.

Conditions

Chemotherapy; Cancer

Keywords

Oncology Nursing; Digital Media; eHealth Literacy

Outcome Measures

Primary Outcomes (1)

• Digital Media Use Level

  Digital media use will be evaluated based on frequency, duration, and purpose of use through a structured questionnaire.

  At baseline (during chemotherapy treatment)

Secondary Outcomes (1)

• eHealth Literacy Level

  At baseline

Other Outcomes (1)

• Relationship Between Digital Media Use and eHealth Literacy

  At baseline

Study Arms (1)

Chemotherapy Patients

Patients receiving chemotherapy whose digital media use and eHealth literacy are assessed.

Other: No Intervention (Observational Study)

Interventions

No Intervention (Observational Study) OTHER

This is an observational study with no assigned intervention. Data will be collected through surveys assessing digital media use and eHealth literacy.

Chemotherapy Patients

Eligibility Criteria

• Age: 18 Years - 67 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients aged between 18 and 67 years receiving chemotherapy treatment in an outpatient setting will be included in the study. Participants will be selected according to the inclusion and exclusion criteria and will voluntarily agree to participate.

You may qualify if:

• Patients aged between 18 and 67 years
• Receiving chemotherapy treatment
• Able to communicate and understand the study procedures
• Voluntarily agree to participate in the study

You may not qualify if:

• Patients with cognitive impairment or communication difficulties
• Patients who refuse to participate
• Patients with incomplete questionnaire responses

Sponsors & Collaborators

• Fenerbahce University: lead

Study Sites (1)

Acıbadem University Atakent Hospital

Istanbul, Küçükçekmece, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Neoplasms

Interventions

Observation

Intervention Hierarchy (Ancestors)

Methods; Investigative Techniques

Study Officials

• Emine Ilayda Yildiz

  Fenerbahce University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Emine Ilayda Yildiz, RN

CONTACT

+905436411944; emineeilaydaa@gmail.com

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Nurse

Study Record Dates

• First Submitted: March 24, 2026
• First Posted: March 30, 2026
• Study Start: April 20, 2026
• Primary Completion: May 20, 2026
• Study Completion: May 20, 2026
• Last Updated: April 21, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)